Tectonic Therapeutic, Inc.
NASDAQTectonic Therapeutic heads into its August 7 earnings print carrying one of the more charged short-versus-analyst divergences in small-cap biotech. Short interest is running at a genuinely elevated 10.3% of the free float — down roughly 9% from a month ago but still high enough to matter. The ORTEX short score of 79.8 places the stock near the top of the bearish-pressure universe…
Snapshot as of 7 Aug 2026
Tectonic Therapeutic heads into its August 7 earnings print carrying one of the more charged short-versus-analyst divergences in small-cap biotech. Short interest is running at a genuinely elevated 10.3% of the free…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TECX — free to start on ORTEX.
Sign up for free →Open TECX on ORTEX